Interaction between corticotropin-releasing factor and nitric oxide in mediating the response of the rat hypothalamus to immune and non-immune stimuli

Molecular Brain Research

Volumn 57, Issue 1, 1998, Pages 54-62

  Lee, Soon ^a   Rivier, Catherine ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Corticotropin releasing factor; Hypothalamus; Interleukin 1 ; Nitric oxide; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HETEROGENEOUS NUCLEAR RNA; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; HYPOTHALAMUS; IMMEDIATE EARLY GENE; IMMUNOSTIMULATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; TRANSCRIPTION REGULATION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE; CORTICOTROPIN-RELEASING HORMONE; DNA-BINDING PROTEINS; ELECTROSHOCK; ENZYME INHIBITORS; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, HETEROGENEOUS NUCLEAR; RNA, MESSENGER; STRESS; TRANSCRIPTION FACTORS; VASOPRESSINS;

ANIMALIA;

EID: 0032102305     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00064-3     Document Type: Article

References (60)

1. S. Amir, Nitric Oxide Signalling in the Hypothalamus, in: Nitric Oxide in the Nervous System, Academic Press, New York, 1995, pp. 151-162.
2. Amir S., Rackover M., Funk D. Blockers of nitric oxide synthase inhibit stress activation of c-fos expression in neurons of the hypothalamic paraventricular nucleus in the rat. Neuroscience. 77:1997;623-627.
3. Arevalo A., Sanchez F., Alonso J.R., Carretero J., Vazquez R., Aijon J. NADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res. Bull. 28:1992;599-603.
4. Buttery L.D.K., Evans T.J., Springall D.R., Carpenter A., Cohen J., Polak J.M. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab. Invest. 71:1994;755-764.
5. Calzà L., Giardino L., Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroendocrinology. 4:1993;627-630.
6. Chan R., Sawchenko P. Hemodynamic regulation of tyrosine hydroxylase messenger RNA in medullary catecholamine neurons: a c-fos-guided hybridization histochemical study. Neuroscience. 66:1995;377-390.
7. Costa A., Trainer P., Besser M., Grossman A. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res. 605:1993;187-192.
8. Ericsson A., Kovács K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
9. J.M. Fukuto, G. Chaudhuri, Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition, Annu. Rev. Pharmacol. Toxicol., 1995, 165-194.
10. Gulyas J., Rivier C., Perrin M., Koerber S., Sutton S., Corrigan A., Lahrichi S., Craig A., Vale W., Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor (CRF). Proc. Natl. Acad. Sci. U.S.A. 92:1995;10575-10579.
11. Hatakeyama S., Kawai Y., Ueyama T., Senba E. Nitric oxide synthase-containing magnocellular neurons of the rat hypothalamus synthesize oxytocin and vasopressin and express Fos following stress stimuli. J. Chem. Neuroanat. 11:1996;243-256.
12. Hernandez J.-F., Kornreich W., Rivier C., Miranda A., Yamamoto G., Andrews J., Taché Y., Vale W., Rivier J. Synthesis and relative potencies of new constrained CRF antagonists. J. Med. Chem. 36:1993;2860-2867.
13. Imaki T., Naruse M., Harada S., Chikada N., Imaki J., Onodera H., Demura H., Vale W. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 38:1996;166-170.
14. A.T.K. Jackson, L. Janz, A.H. Greenberg, D.M. Nance, Central nitric oxide synthase inhibition blocks endotoxin-induced c-fos protein in the hypothalamus, Society for Neuroscience Annual Meeting, San Diego, CA, November 11-16, 1995, p. 1152.
15. Ju G., Zhang X., Jin B.-Q., Huang C.-S. Activation of corticotropin-releasing factor-containing neurons in the paraventricular nucleus of the hypothalamus by interleukin-1 in the rat. Neurosci. Lett. 132:1991;151-154.
16. Karanth S., Lyson K., McCann S.M. Role of nitric oxide in interleukin-2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3383-3387.
17. Kishimoto J., Tsuchiya T., Emson P.C., Nakayama Y. Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) and mRNA and protein in hypothalamic-pituitary-adrenal axis in rats. Brain Res. 720:1996;159-171.
18. Klatt P., Schmidt K., Brunner F., Mayer B. Inhibitors of brain nitric oxide synthase. J. Biol. Chem. 269:1994;1674-1680.
19. Kornreich W.D., Galyean R., Hernandez J.-F., Craig A.G., Donaldson C.J., Yamamoto G., Rivier C., Vale W., Rivier J. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. J. Med. Chem. 35:1992;1870-1876.
20. Kovacs K.J., Sawchenko P.E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 16:1996;262-273.
21. Krukoff T.L., Khalili P. Stress-induced activation of nitric oxide-producing neurons in the rat brain. J. Comp. Neurol. 377:1997;509-519.
22. Lee S., Rivier C. Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1β systemically or into the brain ventricles. J. Neuroendocrinol. 6:1994;217-224.
23. Lee S., Rivier C. Interaction between alcohol and interleukin-1β on ACTH secretion and the expression of immediate early genes in the hypothalamus. Mol. Cell. Neurosci. 5:1994;442-450.
24. Lee S., Barbanel G., Rivier C. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts. Brain Res. 705:1996;136-148.
25. Li H.-Y., Ericsson A., Sawchenko P.E. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2359-2364.
26. J.E. Macdonald, Nitric oxide synthase inhibitors, in: Annual Reports in Medicinal Chemistry, Vol. 31, Academic Press, New York, 1996, pp. 221-230.
27. Maecker H., Desai A., Dash R., Rivier J., Vale W., Sapolsky R. Astressin, a novel and potent CRf antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res. 744:1997;166-170.
28. Martínez V., Rivier J., Wang L., Taché Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF-and stress-related alterations of gastric and colonic motor function. J. Pharmacol. Exp. Ther. 280:1997;754-760.
29. B. Mayer, Biochemistry and molecular pharmacology of nitric oxide synthases, in: Nitric Oxide in the Nervous System, Academic Press, New York, 1995, pp. 21-42.
30. McCoy J.G., Matta S.G., Sharp B.M. Prostaglandins mediate the ACTH response to interleukin-1-beta instilled into the hypothalamic median eminence. Neuroendocrinology. 60:1994;426-435.
31. Minc-Golomb D., Tsarfaty I., Scheartz J.P. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br. J. Pharmacol. 112:1994;720-722.
32. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
33. Okamura H., Miyagawa A., Takagi H., Esumi H., Yanaihara N., Ibata Y. Co-existence of PACAP and nitric oxide synthase in the rat hypothalamus. NeuroReport. 5:1994;1177-1180.
34. Ota M., Crofton J.T., Festavan G.T., Share L. Evidence that nitric oxide can act centrally to stimulate vasopressin release. Neuroendocrinology. 57:1993;955-959.
35. Parkes D., Rivest S., Lee S., Rivier C., Vale W. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Mol. Endocrinol. 7:1994;1357-1367.
36. Parsadaniantz S.M., Levin N., Lenoir V., Roberts J.L., Kerdelhué B. Human interleukin 1β: corticotropin releasing factor and ACTH release and gene expression in the male rat: in vivo and in vitro studies. J. Neurosci. Res. 37:1994;675-682.
37. Rivest S., Rivier C. Lesions of the hypothalamic PVN partially attenuate the stimulatory action of alcohol on ACTH secretion in the rat. Am. J. Physiol. 266:1994;R553-R558.
38. Rivest S., Rivier C. Stress and interleukin-1β-induced activation of c-fos, NGFI-β and CRF gene expression in the hypothalamic PVN: comparison between Sprague-Dawley, Fisher-344 and Lewis rats. J. Neuroendocrinol. 6:1994;101-117.
39. Rivier C. Endogenous nitric oxide participates in the activation of the hypothalamic-pituitary-adrenal axis by noxious stimuli. Endocr. J. 2:1994;367-373.
40. Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front. Neuroendocrinol. 16:1995;151-182.
41. Rivier C., Shen G. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1β, vasopressin and oxytocin. J. Neurosci. 14:1994;1985-1993.
42. Rivier C., Vale W. Cytokines act within the brain to inhibit LH secretion and ovulation in the rat. Endocrinology. 127:1990;849-856.
43. Sanchez F., Alonso J., Arevalo R., Blanco E., Aijon J., Vasquez R. Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat. Cell Tissue Res. 276:1994;31-34.
44. Sanchez F., Rubio M., Hernandez V., Santos M., Carretero J., Vasquez R., Vasquez R. NADPH-diaphorase activity and vasopressin in the paraventricular nucleus of the hypothalamus following adrenalectomy. Neuropeptides. 30:1996;515-520.
45. Sandi C., Guaza C. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β Eur. J. Pharmacol. 274:1995;17-23.
46. Saphier D., Ovadia H. Selective facilitation of putative corticotropin-releasing factor-secreting neurons by interleukin-1. Neurosci. Lett. 114:1990;283-288.
47. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522-524.
48. Siaud P., Mekaouche M., Ixart G., Balmefrezol M., Givalois L., Barbanel G., Assenmacher I. A subpopulation of corticotropin-releasing hormone neurosecretory cells in the paraventricular nucleus of the hypothalamus also contain NADPH-diaphorase. Neurosci. Lett. 170:1994;51-54.
49. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
50. S.H. Snyder, T.M. Dawson, Nitric oxide and related substances as neural messengers, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 609-618.
51. M. Spina, F. Menzaghi, V. Risborough, K. Britton, E. Merlo-Pich, J. Rivier, W. Vale, G. Koob, The behavioral effect of central administration of the novel CRF antagonist astressin, Society for Neuroscience Annual Meeting, San Diego, CA, November 11-16, 1995, p. 756.
52. Suda T., Tozawa F., Ushiyama T., Sumitomo T., Yamada M., Demura H. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology. 126:1990;1223-1228.
53. L.W. Swanson, P.E. Sawchenko, R.W., Lind, Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response, in: T. Hokfelt, K. Fuxe, B. Pernow (Eds.), Progress in Brain Research, Vol. 68, Elsevier, Amsterdam, 1986, pp. 169-190.
54. Torres G., Lee S., Rivier C. Ontogeny of the rat hypothalamic nitric oxide synthase and colocalization with neuropeptides. Mol. Cell. Neurosci. 4:1993;155-163.
55. Turnbull A.V., Rivier C. Selective inhibitors of nitric oxide synthase (NOS) implicate a constitutive isoform of NOS in the regulation of interleukin-1-induced ACTH secretion in rats. Endocrine. 5:1996;135-140.
56. Vanhatalo S., Soinila S. Nitric oxide synthase in the hypothalamo-pituitary pathways. J. Chem. Neuroanat. 8:1995;165-173.
57. Vincent S.R. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog. Neurobiol. 42:1994;129-160.
58. Watanobe H., Sasaki S., Takebe K. Role of prostaglandins E1, E2 and F2α in the brain of interleukin-1β-induced adrenocorticotropin secretion in the rat. Cytokine. 7:1995;710-712.
59. Watanobe H., Susaki S., Takebe K. Involvement of oxytocin and cholecystokinin-8 in interleukin-1β-induced adrenocorticotropin secretion in the rat. Neuroimmunomodulation. 2:1995;88-91.
60. Yamamoto T., Kimura T., Ota K., Shoji M., Inoue M., Ohta M., Sato K., Funyu T., Abe K. Effects of a nitric oxide synthase inhibitor on vasopressin and atrial natriuretic hormone release, thermogenesis and cardiovascular functions in response to interleukin-1β in rats. Tohoku J. Exp. Med. 174:1994;59-69.